Trials / Recruiting
RecruitingNCT05486832
"TARGET Study": Safety and Performance of the Cardiovalve TR Replacement System
"TARGET Study": Safety and Performance of the Cardiovalve TR Replacement System for Tricuspid Regurgitation
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Cardiovalve Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the safety and performance of Cardiovalve TR system
Detailed description
The study is a multi-center, prospective, single arm study designed to evaluate the safety and performance of the Cardiovalve Tricuspid Valve Replacement System
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cardiovalve TR valve replacement System | The Cardiovalve system includes a valve and delivery system, designed for replacement of the tricuspid valve through a transcatheter. |
Timeline
- Start date
- 2022-12-09
- Primary completion
- 2026-08-15
- Completion
- 2033-12-15
- First posted
- 2022-08-04
- Last updated
- 2026-01-05
Locations
7 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT05486832. Inclusion in this directory is not an endorsement.